The Discounted Cash Flow (DCF) valuation of bluebird bio Inc (BLUE) is (1,137.80) USD. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on DCF is -22993.4%.
Based on the latest price of 4.97 USD and our DCF valuation, bluebird bio Inc (BLUE) is a sell. selling BLUE stocks now will result in a potential gain of 22993.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 6.6% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (2,572.79) - (756.71) | (1,137.80) |
| Upside | -51866.4% - -15325.5% | -22993.4% |